Dr. Kyriakos P. Papadopoulos is the Co-Director of Clinical Research at START in San Antonio. He is board-certified in Internal Medicine, Medical Oncology & Hematology. His clinical interests include drug development and malignancies of the upper gastrointestinal-tract and lungs.
Dr. Papadopoulos completed his MBBCh and MSc (Med) at the University of Witwatersrand, Johannesburg, and his specialty training in Internal Medicine at Groote Schuur Hospital, Cape Town, South Africa. He followed this with a fellowship in Medical Oncology and Hematology at the College of Physicians and Surgeons of Columbia University, NY.
Prior to his arrival in San Antonio, Dr. Papadopoulos was the Florence Irving Assistant Professor of Medicine at the College of Physicians and Surgeons of Columbia University, where he was co-director of the GI and Lung Tumor Clinic. He received a Career Development Award from the National Institute of Health, as well as immunotherapy research funding from the Cancer Research Institute.
Dr. Papadopoulos was appointed Clinical Associate Professor of Medicine, University of Texas Health Science Center at San Antonio. He was also senior clinical investigator at the Cancer Therapy & Research Center’s (CTRC) Institute for Drug Development, San Antonio, TX and a member of the CTRC’s Medical Executive Committee.
He is a member of the American Society of Clinical Oncology the American Society of Hematology, the American Association for Cancer Research, Southwest Oncology Group and a Fellow of the College of Physicians of South Africa.
Dr. Papadopoulos serves as a reviewer for a number of oncology journals and has authored numerous peer reviewed articles, chapters and abstracts at international meetings.